Skip to main content

Table 3 Baseline assessment and changes in secondary outcomes from baseline to 10 weeks

From: Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial

Variable

Intervention group

Control group

Between group change

p

Total PA1 (METmin/week), mean±SD

    

 baseline

3282±3118

3770±3071

 

0.20†

 at 10 weeks

4992±5089

4497±4586

  

 change

1709±4430

727±4887

982

0.17‡

Moderate PA1 (METmin/week), mean±SD

    

 baseline

1568±1990

2061±2334

 

0.07†

 at 10 weeks

2518±3026

2346±3479

  

 change

950±2849

285±3842

665

0.19‡

Vigorous PA1 (METmin/week), mean±SD

    

 baseline

486±2036

311±853

 

0.74†

 at 10 weeks

979±2992

591±1559

  

 change

493±2445

279±1619

214

0.54‡

Walking PA1 (METmin/week), mean±SD

    

 baseline

1228±1441

1398±1564

 

0.44†

 at 10 weeks

1495±1617

1560±1687

  

 change

266±1988

163±2096

103

0.74‡

Pedometer2 determined steps/day, mean±SD

    

 baseline

6872±3585

7215±3368

 

0.61‡

 at 10 weeks

8128±4050

6788±3507

  

 change

1256±1933

−426±2754

1340

<0.001‡

SF36 PCS3, mean±SD

    

 baseline

40.4±7.7

41.2±5.9

 

0.51‡

 at 10 weeks

39.4±7.5

40.2±7.8

  

 change

−0.9±8.5

−1.0±7.6

0.1

0.96‡

SF36 MCS3, mean±SD

    

 baseline

35.6±8.7

35.8±7.9

 

0.89‡

 at 10 weeks

34.8±7.9

35.3±7.4

  

 change

−0.9±7.6

−0.5±6.8

0.4

0.77‡

BSI_PST4, mean±SD

    

 baseline

27.6±12.6

26.5±13.8

 

0.60‡

 at 10 weeks

25.3±12.8

24.0±14.5

  

 change

−2.4±9.5

−2.5±7.5

0.1

0.92‡

  1. PA, physical activity; PCS, physical component score; MCS, mental component score; BSI_PST, Brief Symptom Inventory Positive Symptom Total.
  2. 1Intervention group, n=127; Control group, n=60; 2 Intervention group, n=92; control group, n=40; 3Intervention group, n=112; control group, n=51; 4Intervention group, n=116; control group, n=55.
  3. ‡Independent Samples T-test, †Mann Whitney U test.